These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7694634

  • 1. Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
    Lepage E, Gisselbrecht C, Haioun C, Sebban C, Tilly H, Bosly A, Morel P, Herbrecht R, Reyes F, Coiffier B.
    Ann Oncol; 1993 Sep; 4(8):651-6. PubMed ID: 7694634
    [Abstract] [Full Text] [Related]

  • 2. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.
    Haioun C, Lepage E, Gisselbrecht C, Salles G, Coiffier B, Brice P, Bosly A, Morel P, Nouvel C, Tilly H, Lederlin P, Sebban C, Brière J, Gaulard P, Reyes F.
    J Clin Oncol; 2000 Aug; 18(16):3025-30. PubMed ID: 10944137
    [Abstract] [Full Text] [Related]

  • 3. Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
    Morel P, Dupriez B, Herbrecht R, Bastion Y, Tilly H, Delannoy A, Haioun C, Nouvel C, Bouabdallah K, Baumelou E.
    Br J Cancer; 1994 Jul; 70(1):154-9. PubMed ID: 7517172
    [Abstract] [Full Text] [Related]

  • 4. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.
    Haioun C, Lepage E, Gisselbrecht C, Coiffier B, Bosly A, Tilly H, Morel P, Nouvel C, Herbrecht R, D'Agay MF.
    J Clin Oncol; 1994 Dec; 12(12):2543-51. PubMed ID: 7527453
    [Abstract] [Full Text] [Related]

  • 5. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.
    Haioun C, Lepage E, Gisselbrecht C, Bastion Y, Coiffier B, Brice P, Bosly A, Dupriez B, Nouvel C, Tilly H, Lederlin P, Biron P, Brière J, Gaulard P, Reyes F.
    J Clin Oncol; 1997 Mar; 15(3):1131-7. PubMed ID: 9060555
    [Abstract] [Full Text] [Related]

  • 6. Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA).
    Mounier N, Haioun C, Cole BF, Gisselbrecht C, Sebban C, Morel P, Marit G, Bouabdallah R, Ravoet C, Salles G, Reyes F, Lepage E.
    Blood; 2000 Jun 15; 95(12):3687-92. PubMed ID: 10845898
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.
    Coiffier B, Gisselbrecht C, Vose JM, Tilly H, Herbrecht R, Bosly A, Armitage JO.
    J Clin Oncol; 1991 Feb 15; 9(2):211-9. PubMed ID: 1703226
    [Abstract] [Full Text] [Related]

  • 8. Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
    Diviné M, Lepage E, Brière J, Pautier P, Dupriez B, Lederlin P, Mineur P, Tilly H, Blanc M, Audhuy B, Herbrecht R, Coiffier B, Reyes F.
    J Clin Oncol; 1996 Jan 15; 14(1):240-8. PubMed ID: 8558204
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Hermine O, Haioun C, Lepage E, d'Agay MF, Briere J, Lavignac C, Fillet G, Salles G, Marolleau JP, Diebold J, Reyas F, Gaulard P.
    Blood; 1996 Jan 01; 87(1):265-72. PubMed ID: 8547651
    [Abstract] [Full Text] [Related]

  • 10. Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte.
    Tilly H, Mounier N, Lederlin P, Brière J, Dupriez B, Sebban C, Bosly A, Biron P, Nouvel C, Herbrecht R, Bordessoule D, Coiffier B.
    J Clin Oncol; 2000 Mar 01; 18(6):1309-15. PubMed ID: 10715302
    [Abstract] [Full Text] [Related]

  • 11. Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
    Brice P, Cazals D, Mounier N, Verola O, Neidhart-Berard AM, Remenieras L, Deconinck E, Doyen C, Hamelsand J, Molina T, Moulonguet I, Gisselbrecht C.
    Leukemia; 1998 Feb 01; 12(2):213-9. PubMed ID: 9519784
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte.
    Mounier N, Gisselbrecht C, Brière J, Haioun C, Feugier P, Offner F, Recher C, Stamatoullas A, Morschhauser F, Macro M, Thieblemont C, Sonet A, Fabiani B, Reyes F, Groupe d'Etude des Lymphomes de l'Adulte.
    J Clin Oncol; 2004 Jul 15; 22(14):2826-34. PubMed ID: 15254050
    [Abstract] [Full Text] [Related]

  • 13. Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs.
    Salles G, Herbrecht R, Tilly H, Berger F, Brousse N, Gisselbrecht C, Coiffier B.
    Am J Med; 1991 Jan 15; 90(1):77-84. PubMed ID: 1702581
    [Abstract] [Full Text] [Related]

  • 14. Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.
    Gisselbrecht C, Haioun C, Lepage E, Bastion Y, Tilly H, Bosly A, Dupriez B, Marit G, Herbrecht R, Deconinck E, Marolleau JP, Yver A, Dabouz-Harrouche F, Coiffier B, Reyes F.
    Leuk Lymphoma; 1997 Apr 15; 25(3-4):289-300. PubMed ID: 9168439
    [Abstract] [Full Text] [Related]

  • 15. Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective.
    Coiffier B, Reyes F, Groupe d'Etude des Lymphomes de l'Adulte.
    Oncology (Williston Park); 2005 Apr 15; 19(4 Suppl 1):7-15. PubMed ID: 15934513
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of fludarabine/mitoxantrone/dexamethasone alternating with CHOP in bulky follicular non-Hodgkin's lymphoma.
    Wilder DD, Ogden JL, Jain VK.
    Clin Lymphoma; 2002 Mar 15; 2(4):229-37. PubMed ID: 11970762
    [Abstract] [Full Text] [Related]

  • 17. VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.
    Herbrecht R, Garcia JJ, Bergerat JP, Dufour P, Duclos B, Oberling F.
    Cancer Chemother Pharmacol; 1989 Mar 15; 24(5):338-9. PubMed ID: 2474382
    [Abstract] [Full Text] [Related]

  • 18. Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
    Jost LM, Jacky E, Dommann-Scherrer C, Honegger HP, Maurer R, Sauter C, Stahel RA.
    Ann Oncol; 1995 May 15; 6(5):445-51. PubMed ID: 7545428
    [Abstract] [Full Text] [Related]

  • 19. Etoposide, ifosfamide and methotrexate combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma after failure of the LNH 84 regimen.
    Herbrecht R, Ortiz S, Damonte JC, Liu KL, Maloisel F, Dufour P, Bergerat JP, Oberling F.
    Hematol Oncol; 1991 May 15; 9(4-5):253-7. PubMed ID: 1720760
    [Abstract] [Full Text] [Related]

  • 20. Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.
    Bastion Y, Blay JY, Divine M, Brice P, Bordessoule D, Sebban C, Blanc M, Tilly H, Lederlin P, Deconinck E, Salles B, Dumontet C, Brière J, Coiffier B.
    J Clin Oncol; 1997 Aug 15; 15(8):2945-53. PubMed ID: 9256139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.